Rather than adapting legacy materials or re-branding an existing course, BARBRI rebuilt its NextGen offering from the ground up. Every element of the course is intentionally designed to align with the ...

Zachary Goldberg was frustrated. In summer 2024, the then-IU sophomore was studying for the Law School Admission Test while abroad in Budapest when he realized none of the existing prep platforms felt ...

We are happy to be able to offer LSAT Prep to Juniors and Seniors planning to study for the LSAT exam and attend law school! This Short Term, Purposeful Work is bringing Ben Paris, J.D., whom Blake ...

The Dell XPS 14 brings the company’s flagship laptop back into competition with speedy Intel Core Series 3 chips and a redesign that’s more practical, yet still premium. In 2022, Dell took a big swing ...

The Food and Drug Administration reversed course and agreed to begin a review of Moderna’s MRNA1.16%increase; green up pointing triangle application to sell a new seasonal flu shot after the vaccine ...

The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA flu vaccine candidate after holding a high-priority meeting with the company.

Moderna said Wednesday the Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a week after rejecting the original submission and fueling ...

University of Houston professors could soon be required to self-evaluate their curricula to ensure that course material doesn't promote "personal or institutional advocacy." The five-page proposed ...

The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday. About two weeks ago, the FDA sent Moderna a ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — The Food and Drug ...

The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, company and federal officials said ...

Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology. By Christina Jewett and ...